{"id":1648,"date":"2011-10-26T10:22:55","date_gmt":"2011-10-26T10:22:55","guid":{"rendered":"https:\/\/bendalis.com\/kooperationen-mit-eusa-pharma-und-riemser-arzneimittel-ag\/"},"modified":"2026-04-30T14:19:19","modified_gmt":"2026-04-30T14:19:19","slug":"cooperation-with-eusa-pharma-and-riemser-arzneimittel-ag","status":"publish","type":"post","link":"https:\/\/bendalis.com\/en\/kooperationen-mit-eusa-pharma-und-riemser-arzneimittel-ag\/","title":{"rendered":"Cooperations with EUSA Pharma and Riemser Arzneimittel AG"},"content":{"rendered":"<p class=\"wp-block-paragraph\">In 2009, Bendalis GmbH entered into a cooperation agreement with Eusa Pharma, a pharmaceutical company operating in the USA and Europe, for the distribution of Caphosol\u00ae.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Since the beginning of 2011, a co-promotion agreement has been in place with Riemser Arzneimittel AG for Aloxi\u00ae (Palonosetron), an innovative 5HT3 receptor antagonist for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV).<\/p>","protected":false},"excerpt":{"rendered":"<p>In 2009, Bendalis GmbH entered into a cooperation with the US and European pharmaceutical company Eusa Pharma for the distribution of Caphosol\u00ae. Since the beginning of 2011, there has been a co-promotion agreement with Riemser Arzneimittel AG for Aloxi\u00ae (palonosetron), an innovative 5-HT3 receptor antagonist for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV).<\/p>","protected":false},"author":3,"featured_media":1613,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_seopress_robots_follow":"","_seopress_robots_imageindex":"","_seopress_robots_snippet":"","_seopress_robots_primary_cat":"","_seopress_robots_breadcrumbs":"","_seopress_robots_freeze_modified_date":"","_seopress_robots_custom_modified_date":"","_seopress_robots_canonical":"","_seopress_social_fb_title":"","_seopress_social_fb_desc":"","_seopress_social_fb_img":"","_seopress_social_fb_img_attachment_id":0,"_seopress_social_fb_img_width":0,"_seopress_social_fb_img_height":0,"_seopress_social_twitter_title":"","_seopress_social_twitter_desc":"","_seopress_social_twitter_img":"","_seopress_social_twitter_img_attachment_id":0,"_seopress_social_twitter_img_width":0,"_seopress_social_twitter_img_height":0,"_seopress_redirections_value":"","_seopress_redirections_enabled":"","_seopress_redirections_enabled_regex":"","_seopress_redirections_logged_status":"","_seopress_redirections_param":"","_seopress_redirections_type":0,"_seopress_analysis_target_kw":"","footnotes":""},"categories":[4],"tags":[],"class_list":["post-1648","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-aktuelles"],"_links":{"self":[{"href":"https:\/\/bendalis.com\/en\/wp-json\/wp\/v2\/posts\/1648","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bendalis.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bendalis.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bendalis.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/bendalis.com\/en\/wp-json\/wp\/v2\/comments?post=1648"}],"version-history":[{"count":2,"href":"https:\/\/bendalis.com\/en\/wp-json\/wp\/v2\/posts\/1648\/revisions"}],"predecessor-version":[{"id":2336,"href":"https:\/\/bendalis.com\/en\/wp-json\/wp\/v2\/posts\/1648\/revisions\/2336"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bendalis.com\/en\/wp-json\/wp\/v2\/media\/1613"}],"wp:attachment":[{"href":"https:\/\/bendalis.com\/en\/wp-json\/wp\/v2\/media?parent=1648"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bendalis.com\/en\/wp-json\/wp\/v2\/categories?post=1648"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bendalis.com\/en\/wp-json\/wp\/v2\/tags?post=1648"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}